Infant Formula with 2FL and LNnT for Satiety Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current solutions for reducing food intake and promoting healthy growth in infants and young children, such as using short chain fatty acids, face challenges like unpalatability and regulatory issues, and there is a need for more natural and effective alternatives that mimic the benefits of breast milk.
Innovation Solution
A nutritional composition comprising fucosylated oligosaccharides and N-acetylated oligosaccharides, specifically 2′-fucosyllactose and lacto-N-neotetraose, which increases colonic propionate production, thereby reducing food intake and promoting healthy growth by enhancing satiety and lean mass while reducing fat content.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If short chain fatty acids (SCFAs) are used to reduce food intake and enhance satiety, then appetite regulation and weight management are improved, but the composition becomes unpalatable and faces regulatory issues
Solution Approach 1:
The patent uses prebiotic oligosaccharides (GOS and FOS) as intermediary substances that indirectly produce SCFAs through colonic fermentation. Instead of directly administering SCFAs which are unpalatable and regulated, the composition provides substrates that the gut microbiota converts into SCFAs naturally, bypassing the palatability and regulatory issues while achieving the same satiety-enhancing effect
Solution Approach 2:
The patent replaces the direct chemical approach (administering SCFAs) with a biological approach (using prebiotics fermented by gut microbiota). This substitution transforms the mechanism from direct chemical supplementation to indirect biological production, eliminating the need to deal with SCFA unpalatability and regulatory restrictions while maintaining the therapeutic effect
2Reliability
If breast milk is used to provide natural satiety factors, then satiety responsiveness and healthy growth are improved, but breastfeeding may be inadequate or unsuccessful for medical reasons or maternal choice
Solution Approach 1:
The patent creates an artificial composition that copies the key functional components of breast milk (prebiotic oligosaccharides like GOS and FOS) without requiring actual breast milk. This copying approach replicates the satiety-enhancing and growth-promoting effects of breast milk while providing a universally available alternative for situations where breastfeeding is not possible
Solution Approach 2:
The patent develops a universal infant formula composition that can serve all infants regardless of breastfeeding availability. The composition combines multiple prebiotic oligosaccharides to achieve multiple functions: enhancing satiety, promoting healthy growth, and supporting gut development, making it applicable to all infants needing formula supplementation or replacement
3Adaptability or versatility
If formula feeding is used as alternative to breastfeeding, then feeding accessibility is improved, but feeding volumes are significantly higher and satiety responsiveness is reduced
Solution Approach 1:
The patent modifies the compositional parameters of infant formula by incorporating specific ratios of prebiotic oligosaccharides (GOS and FOS). This parameter change transforms the formula's effect on gut microbiota and SCFA production, thereby improving satiety responsiveness and reducing feeding volumes to levels more comparable to breastfed infants
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively regulates food intake and promotes healthy growth by increasing colonic propionate production, mimicking the satiety-enhancing effects of breast milk, and is suitable for infants and young children, offering a natural and effective alternative to existing solutions.
Implementation Method 1
Specific delivery systems targeting the release of propionate in the proximal colon have therefore been developed. The majority of propionate chemically bound to inulin should only be released when the inulin polymer is fermented by the colonic microbiota
Data Source
AI summary
The present invention relates to a nutritional composition comprising at least one fucosylated oligosaccharide and at least one N-acetylated oligosaccharide, for use in reducing and/or controlling food intake in an infant or a young child, and/or for use in promoting a healthy growth in an infant or a young child.